Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic Non-small Cell Lung Cancer With HER2 Mutations [Phase 3]
A Phase 3 clinical trial of SHR-A1811 is ongoing as first-line treatment for advanced or metastatic non-small cell lung cancer with HER2 mut…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Australian Retrospective Analysis of EGFRm Advanced & Metastatic NSCLC Patients Treated With 1L or 2L Osimertinib.
Australian retrospective analysis of patients with EGFR-mutant advanced or metastatic non-small cell lung cancer treated with first- or seco…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating first-line combination of ipilimumab, nivolumab, and N-803 for stage IV or recurrent non-small cell lung cancer; th…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients [NA]
A prospective, longitudinal biocollection in thoracic oncology enrolling newly diagnosed lung cancer patients to collect biological samples …
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors. [Phase 1]
A Phase 1 study evaluating DKY709 alone or in combination with PDR001 in patients with advanced solid tumors. The enrolled diseases include …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors [Phase 1]
Phase 1 study of GNC-077 in patients with non-small cell lung cancer and other solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia
This AstraZeneca-sponsored clinical trial assesses chemo-radiation therapy patterns and short-term outcomes in routine practice for unresect…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors [Phase 2]
Phase 2 clinical trial update for BL-B01D1 in combination with a PD-1 monoclonal antibody in locally advanced or metastatic non-small cell l…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status [Phase 2]
Phase 2 study evaluating adagrasib in KRAS G12C-mutant non-small cell lung cancer patients who are elderly or have poor performance status; …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study in Non-Small Cell Lung Cancer
A clinical trial in non-small cell lung cancer sponsored by N-Power Medicine is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating Quaratusugene Ozeplasmid (Reqorsa) in combination with Osimertinib for advanced non-small cell l…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLC [Phase 2]
This clinical trial update reports a Phase 2 study evaluating the combination of savolitinib with durvalumab in EGFR wild-type locally advan…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer [NA]
This Boehringer Ingelheim-sponsored trial compares tissue and liquid biopsies across multiple cancers—non-small cell lung cancer, colorectal…
-
CLINICAL_TRIALS other · 2026-01-21Clinical Trial Update: Plasma-Adapted First-Line Pembro In NSCLC [Phase 2]
Phase 2 trial update on plasma-adapted pembrolizumab as first-line therapy for non-small cell lung cancer; the study is currently active but…
-
CLINICAL_TRIALS other · 2026-01-21Clinical Trial Update: Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI [Phase 2]
Phase 2 trial evaluating a triplet of amivantamab, lazertinib, and bevacizumab for EGFR-mutant advanced non-small cell lung cancer after pro…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
A clinical trial update discusses safety and efficacy of combining APL-101 with frontline Osimertinib in patients with EGFR-mutated metastat…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: A Study of Vebreltinib and Platinum-Containing Double Agents in Subjects With MET-Positive [Phase 3]
A Phase 3 clinical trial evaluating Vebreltinib in combination with platinum-containing regimens in MET-positive non-small cell lung cancer,…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Induction Lorlatinib in Stage III Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating induction lorlatinib for Stage III non-small cell lung cancer, including patients undergoing surgery. The study i…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients [NA]
Clinical trial LUNG-05 is investigating chemotherapy effectiveness for metastatic non-small cell lung cancer and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: easyEndoTM Powered in Thoracic Surgery [NA]
A clinical trial evaluating the easyEndoTM Powered in Thoracic Surgery for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Radiotherapy Plus Anti-PD-1 Versus Anti-PD-1 Alone in ypTanyN⁺M0 NSCLC [Phase 2]
This is a Phase 2 trial comparing radiotherapy plus a PD-1 inhibitor versus PD-1 inhibitor alone in postoperative ypTanyN+M0 non-small cell …
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Chemotherapy Plus Pitavastatin Guided by Patient-Derived Tumor-like Cell Clusters in Refractory Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating chemotherapy plus pitavastatin guided by patient-derived tumor-like cell clusters in refractory non-small cell lung…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer [EARLY_Phase 1]
Early-phase clinical trial update for universal CAR-T cells REVO-UWD-03 in advanced hepatocellular carcinoma and non-small cell lung cancer,…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI [Phase 1]
This Phase 1 trial investigating Functional Lung Avoidance Radiation Therapy using Hyperpolarized Xenon-129 MRI for non-small cell lung canc…
-
EMA approval · 2026-01-19EMA Authorised: Tagrisso (osimertinib mesilate) — AstraZeneca AB
The European Medicines Agency authorised Tagrisso (osimertinib mesilate) for use in non-small cell lung cancer.